Skip to main content

Meet Your Student Wellness Committee

The mission of the Student Wellness Committee is to offer a system of academic, social, emotional, and psychological support to the students of UCCOM

The SWC takes a two-pronged approach to wellness:

  • Social/wellness activities meant for relaxation, stress-relief, and camaraderie among classmates
  • Advocacy for wellness issues within the curriculum

Advocacy Subcommittee

  • Dan Furrer, Co-president
  • Matthew Martinez
  • Lauren Welt
  • Ellie Rice
  • Olivia Flauto
  • Aja Hill

Culture Subcommittee

  • Evie Rollman, Co-president
  • Raina Rindani
  • Abby Berns
  • Jaycie Gard
  • Abby Roy
  • Baptistine Bonniol
Tammy Mentzel, MPH Named Executive Director for Center Administration

Tammy Mentzel, MPH, has been named Executive Director for Center Administration and Associate Director for Administration at the University of Cincinnati Cancer Center.

Full story About: Tammy Mentzel, MPH Named Executive Director for Center Administration

By:

2024 Annual Student Research Findings Symposium

The Annual Student Research Findings Symposium took place on January 9, 2024 and consisted of one workshop group presentation and two targeted research training presentations.

Full story About: 2024 Annual Student Research Findings Symposium
A Spotlight on Pancreatic Cancer at the Waters Laboratory

Andrew Waters, PhD, a basic scientist at the University of Cincinnati Cancer Center and assistant professor within the Division of Surgical Oncology and the Department of Cancer Biology at UC, runs a research lab focusing on the molecular consequences and resistance mechanisms to KRAS inhibitors.

Full story About: A Spotlight on Pancreatic Cancer at the Waters Laboratory
Clinical Trial Highlight: Phase 2 Study Evaluates LN-145 in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)

The University of Cincinnati Cancer Center Clinical Trials Office recently opened a trial to study the efficacy of LN-145 on patients with advanced lung cancer. This treatment involves the infusion of patients’ own immune cells, tumor-infiltrating lymphocytes (TIL), to evaluate the efficacy of LN-145 as determined by objective response rates (ORR).

Full story About: Clinical Trial Highlight: Phase 2 Study Evaluates LN-145 in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
Intranet Login

Contact Us

Office of Student Affairs
Medical Sciences Building E450G
231 Albert Sabin Way PO BOX 670552
Cincinnati, OH 45267-0552

Mail Location: 0552
Phone: 513-558-0203
Email: marti5cl@ucmail.uc.edu